EP1073710A4 - Elaboration non stochastique de vaccins genetiques et d'enzymes - Google Patents

Elaboration non stochastique de vaccins genetiques et d'enzymes

Info

Publication number
EP1073710A4
EP1073710A4 EP00913378A EP00913378A EP1073710A4 EP 1073710 A4 EP1073710 A4 EP 1073710A4 EP 00913378 A EP00913378 A EP 00913378A EP 00913378 A EP00913378 A EP 00913378A EP 1073710 A4 EP1073710 A4 EP 1073710A4
Authority
EP
European Patent Office
Prior art keywords
enzymes
stochastic generation
genetic vaccines
vaccines
genetic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
EP00913378A
Other languages
German (de)
English (en)
Other versions
EP1073710A2 (fr
EP1073710A3 (fr
Inventor
Jay M Short
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BP Corp North America Inc
Original Assignee
Verenium Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/246,178 external-priority patent/US6171820B1/en
Priority claimed from US09/267,118 external-priority patent/US6238884B1/en
Priority claimed from US09/276,860 external-priority patent/US6352842B1/en
Priority claimed from US09/332,835 external-priority patent/US6537776B1/en
Application filed by Verenium Corp filed Critical Verenium Corp
Priority to EP11167668A priority Critical patent/EP2397549A3/fr
Publication of EP1073710A3 publication Critical patent/EP1073710A3/fr
Publication of EP1073710A2 publication Critical patent/EP1073710A2/fr
Publication of EP1073710A4 publication Critical patent/EP1073710A4/fr
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445—Plasmodium
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/102—Mutagenizing nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/102—Mutagenizing nucleic acids
    • C12N15/1027—Mutagenizing nucleic acids by DNA shuffling, e.g. RSR, STEP, RPR
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1058—Directional evolution of libraries, e.g. evolution of libraries is achieved by mutagenesis and screening or selection of mixed population of organisms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Ecology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
EP00913378A 1999-02-04 2000-02-04 Elaboration non stochastique de vaccins genetiques et d'enzymes Ceased EP1073710A4 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP11167668A EP2397549A3 (fr) 1999-02-04 2000-02-04 Génération non stochastique de vaccins génétiques et enzymes

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US09/246,178 US6171820B1 (en) 1995-12-07 1999-02-04 Saturation mutagenesis in directed evolution
US246178 1999-02-04
US09/267,118 US6238884B1 (en) 1995-12-07 1999-03-09 End selection in directed evolution
US09/276,860 US6352842B1 (en) 1995-12-07 1999-03-26 Exonucease-mediated gene assembly in directed evolution
US09/332,835 US6537776B1 (en) 1999-06-14 1999-06-14 Synthetic ligation reassembly in directed evolution
PCT/US2000/003086 WO2000046344A2 (fr) 1999-02-04 2000-02-04 Elaboration non stochastique de vaccins genetiques et d'enzymes

Publications (3)

Publication Number Publication Date
EP1073710A3 EP1073710A3 (fr) 2000-12-28
EP1073710A2 EP1073710A2 (fr) 2001-02-07
EP1073710A4 true EP1073710A4 (fr) 2007-12-19

Family

ID=27500214

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00913378A Ceased EP1073710A4 (fr) 1999-02-04 2000-02-04 Elaboration non stochastique de vaccins genetiques et d'enzymes

Country Status (3)

Country Link
EP (1) EP1073710A4 (fr)
IL (1) IL138206A (fr)
MX (1) MXPA00009723A (fr)

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991015581A1 (fr) * 1990-04-05 1991-10-17 Roberto Crea Mutagenese 'traversante'
WO1997020078A1 (fr) * 1995-11-30 1997-06-05 Maxygen, Inc. Procede d'elaboration de polynucleotides presentant des caracteristiques desirees par selection iterative et recombinaison
WO1998027230A1 (fr) * 1996-12-18 1998-06-25 Maxygen, Inc. Procedes et compositions pour l'ingenierie des polypeptides
WO1998032845A1 (fr) * 1997-01-24 1998-07-30 Bioinvent International Ab Procede d'evolution moleculaire in vitro de la fonction proteique
WO1998042832A1 (fr) * 1997-03-25 1998-10-01 California Institute Of Technology Recombinaison de sequences de polynucleotides au moyen d'amorces aleatoires ou definies
WO1999041368A2 (fr) * 1998-02-11 1999-08-19 Maxygen, Inc. Optimisation des proprietes immunomodulatrices des vaccins genetiques
WO2000053744A2 (fr) * 1999-03-09 2000-09-14 Diversa Corporation Selection finale d'une evolution dirigee
WO2000058517A1 (fr) * 1999-03-26 2000-10-05 Diversa Corporation Reassemblage d'acide nucleique en evolution dirigee induit par l'exonuclease
WO2000077262A1 (fr) * 1999-06-14 2000-12-21 Diversa Corporation Réassemblage synthétique par ligature à évolution dirigée

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991015581A1 (fr) * 1990-04-05 1991-10-17 Roberto Crea Mutagenese 'traversante'
WO1997020078A1 (fr) * 1995-11-30 1997-06-05 Maxygen, Inc. Procede d'elaboration de polynucleotides presentant des caracteristiques desirees par selection iterative et recombinaison
WO1998027230A1 (fr) * 1996-12-18 1998-06-25 Maxygen, Inc. Procedes et compositions pour l'ingenierie des polypeptides
WO1998032845A1 (fr) * 1997-01-24 1998-07-30 Bioinvent International Ab Procede d'evolution moleculaire in vitro de la fonction proteique
WO1998042832A1 (fr) * 1997-03-25 1998-10-01 California Institute Of Technology Recombinaison de sequences de polynucleotides au moyen d'amorces aleatoires ou definies
WO1999041368A2 (fr) * 1998-02-11 1999-08-19 Maxygen, Inc. Optimisation des proprietes immunomodulatrices des vaccins genetiques
WO2000053744A2 (fr) * 1999-03-09 2000-09-14 Diversa Corporation Selection finale d'une evolution dirigee
WO2000058517A1 (fr) * 1999-03-26 2000-10-05 Diversa Corporation Reassemblage d'acide nucleique en evolution dirigee induit par l'exonuclease
WO2000077262A1 (fr) * 1999-06-14 2000-12-21 Diversa Corporation Réassemblage synthétique par ligature à évolution dirigée

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
MARKS J D ET AL: "Molecular evolution of proteins on filamentous phage. Mimicking the strategy of the immune system", JOURNAL OF BIOLOGICAL CHEMISTRY 1992 UNITED STATES, vol. 267, no. 23, 1992, pages 16007 - 16010, XP002025816, ISSN: 0021-9258 *
REIDHAAR-OLSON J F ET AL: "COMBINATORIAL CASSETTE MUTAGENESIS AS A PROBE OF THE INFORMATIONAL CONTENT OF PROTEIN SEQUENCES", SCIENCE, AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE, US, vol. 241, 1 July 1988 (1988-07-01), pages 53 - 57, XP000652325, ISSN: 0036-8075 *
RIECHMANN L AND WEILL M: "Phage display and selection of a site-directed randomized single-chain antibody Fv fragment for its affinity improvement", BIOCHEMISTRY, AMERICAN CHEMICAL SOCIETY. EASTON, PA, US, vol. 32, no. 34, 31 August 1993 (1993-08-31), pages 8848 - 8855, XP002147197, ISSN: 0006-2960 *
SCHULTZ S ET AL: "Site-saturation studies of beta-lactamase: production and characterization of mutant beta-lactamases with all possible amino acid substitutions at residue 71", March 1986, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE, WASHINGTON, DC, US, PAGE(S) 1588-1592, ISSN: 0027-8424, XP002147196 *
SHANKLIN J ED - ZHANG QIFA WING ROD: "Exploring the possibilities presented by protein engineering", CURRENT OPINION IN PLANT BIOLOGY, QUADRANT SUBSCRIPTION SERVICES, GB, vol. 3, no. 3, 1 January 2000 (2000-01-01), pages 243 - 248, XP004793029, ISSN: 1369-5266 *
SHANKLIN J: "Exploring the possibilities presented by protein engineering", CURRENT OPINION IN PLANT BIOLOGY, QUADRANT SUBSCRIPTION SERVICES, GB, vol. 3, no. 3, 2000, pages 243 - 248, XP004793029, ISSN: 1369-5266 *

Also Published As

Publication number Publication date
IL138206A (en) 2011-06-30
EP1073710A2 (fr) 2001-02-07
MXPA00009723A (es) 2003-09-22
IL138206A0 (en) 2001-10-31

Similar Documents

Publication Publication Date Title
HK1043150A1 (en) Human delta 5-desaturase gene and uses thereof
IL150314A0 (en) Improved lysosomal enzymes and lysosomal enzyme activators
AU1926001A (en) Novel human protein kinases and protein kinase-like enzymes
GB2364059B (en) Beta-Secretase enzyme compositions and methods
HUP0201235A2 (en) Regulation of viral gene expression
EP1178797A4 (fr) Inhibiteurs de l'enzyme impdh
EP1507870A4 (fr) Enzymes dotes d'une activite de deshalogenase et leurs methodes d'utilisation
IL144845A0 (en) Vaccines and gene therapy compositions and methods of making and using the same
IL128193A0 (en) Rhamnosyl-transferase gene and uses thereof
AU2002221755A1 (en) Nucleotide and polypeptide sequence of human lysosomal acid lipase
AU2001283872A1 (en) Regulation of human eosinophil serine protease 1-like enzyme
EP1174499A4 (fr) Nouveau gene amidase
AU2001289104A1 (en) Methods of producing cells and animals comprising targeted gene modifications
IL138206A0 (en) Non-stochastic generation of genetic vaccines and enzymes
EP1197557A4 (fr) Gene codant pour une acylase des lipopeptides cycliques et expression dudit gene
EP1073710A3 (fr) Elaboration non stochastique de vaccins genetiques et d'enzymes
EP1229118A4 (fr) Gene de photosensibilite vegetal et son utilisation
GB0005326D0 (en) Enzymes and uses relating thereto
GB0318112D0 (en) ›-Secretase enzyme compositions and methods
DE60033943D1 (de) Schwefelfreie enzyme
GB9929061D0 (en) Methods of producing novel enzymes
AU6424501A (en) Novel enzyme gene and its expression product
AU4459100A (en) Cell cycle genes and methods of use
AU1654001A (en) Improved physical and thermal treatment of waste
EP1155115A4 (fr) Procede de modification pour cellules cytotoxiques et utilisations correspondantes

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

PUAK Availability of information related to the publication of the international search report

Free format text: ORIGINAL CODE: 0009015

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

AK Designated contracting states

Kind code of ref document: A3

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

RIC1 Information provided on ipc code assigned before grant

Free format text: 7C 12Q 1/68 A, 7C 12N 15/09 B, 7C 07H 21/02 B, 7A 61K 39/00 B

17P Request for examination filed

Effective date: 20010202

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: VERENIUM CORPORATION

A4 Supplementary search report drawn up and despatched

Effective date: 20071120

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 39/00 20060101ALI20071115BHEP

Ipc: C07H 21/02 20060101ALI20071115BHEP

Ipc: C12N 15/09 20060101ALI20071115BHEP

Ipc: C12N 15/10 20060101ALI20071115BHEP

Ipc: C12Q 1/68 20060101AFI20010115BHEP

17Q First examination report despatched

Effective date: 20090529

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: BP CORPORATION NORTH AMERICA INC.

REG Reference to a national code

Ref country code: DE

Ref legal event code: R003

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED

18R Application refused

Effective date: 20141201

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1035003

Country of ref document: HK